Toronto Dominion Bank’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.58K Buy
+9
New +$1.72K ﹤0.01% 2161
2026
Q1
Sell
-7
Closed -$1.11K 2274
2025
Q4
$1.11K Buy
+7
New +$961 ﹤0.01% 1930

Other funds holding LABU

Toronto Dominion Bank's LABU Position: Q2 2026 in Review

Toronto Dominion Bank opened a new position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2026: 9 shares worth $2.58K. The stake represents ﹤0.01% of the portfolio and ranks #2161 among its holdings. This is a return to the name: Toronto Dominion Bank previously reported a position in LABU as recently as Q4 2025.

Toronto Dominion Bank first reported a position in LABU in Q4 2025 and has held it in 2 quarters since. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • Toronto Dominion Bank held 9 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $2.58K as of Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF was a new Toronto Dominion Bank position in Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #2161 holding.
  • Toronto Dominion Bank first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2025 and has held it in 2 quarters since.
  • 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.